We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.32%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$31.9B
AUM Growth
+$2.38B
Cap. Flow
+$1.7B
Cap. Flow %
5.31%
Top 10 Hldgs %
15.42%
Holding
3,195
New
265
Increased
1,619
Reduced
1,032
Closed
182

Sector Composition

Rank Sector Weight
1 Healthcare 9.59%
2 Technology 8.36%
3 Consumer Staples 8.04%
4 Financials 7.78%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
26
McDonald's
MCD
$193B
$177M 0.56%
1,473,872
+54,207
+4% +$6.79M
GE icon
27
GE Aerospace
GE
$364B
$167M 0.52%
1,108,374
+59,600
+6% +$8.69M
EEM icon
28
iShares MSCI Emerging Markets ETF
EEM
$27.5B
$165M 0.52%
4,796,028
+118,894
+3% +$3.99M
WFC icon
29
Wells Fargo
WFC
$254B
$162M 0.51%
3,416,305
-64,969
-2% -$3.17M
UNH icon
30
UnitedHealth
UNH
$382B
$152M 0.48%
1,074,894
-49,088
-4% -$6.55M
BMY icon
31
Bristol-Myers Squibb
BMY
$129B
$151M 0.47%
2,047,653
+195,346
+11% +$13.8M
KMB icon
32
Kimberly-Clark
KMB
$37.6B
$150M 0.47%
1,088,669
+74,639
+7% +$9.77M
RAI
33
DELISTED
Reynolds American Inc
RAI
$149M 0.47%
2,760,757
+120,929
+5% +$6.08M
META icon
34
Meta Platforms (Facebook)
META
$1.49T
$145M 0.45%
1,266,194
+93,865
+8% +$10.8M
GSK icon
35
GSK
GSK
$107B
$144M 0.45%
2,657,638
+197,270
+8% +$10.4M
DUK icon
36
Duke Energy
DUK
$101B
$143M 0.45%
1,664,662
+120,355
+8% +$9.62M
KHC icon
37
Kraft Heinz
KHC
$32.8B
$143M 0.45%
1,610,572
-423,912
-21% -$34.9M
CMCSA icon
38
Comcast
CMCSA
$87.3B
$141M 0.44%
4,314,916
+168,772
+4% +$5.24M
NGG icon
39
National Grid
NGG
$79.3B
$140M 0.44%
1,953,507
+142,717
+8% +$9.88M
UNP icon
40
Union Pacific
UNP
$174B
$140M 0.44%
1,605,408
+101,428
+7% +$8.58M
IEFA icon
41
iShares Core MSCI EAFE ETF
IEFA
$186B
$138M 0.43%
2,651,843
+592,066
+29% +$31.7M
HD icon
42
Home Depot
HD
$337B
$136M 0.43%
1,068,914
+27,537
+3% +$3.64M
OXY icon
43
Occidental Petroleum
OXY
$55.7B
$134M 0.42%
1,769,557
+148,572
+9% +$11.1M
ABBV icon
44
AbbVie
ABBV
$465B
$132M 0.41%
2,126,602
+98,278
+5% +$5.99M
VOD icon
45
Vodafone
VOD
$37.1B
$130M 0.41%
4,192,448
+593,138
+16% +$19.3M
CSCO icon
46
Cisco
CSCO
$443B
$127M 0.4%
4,430,339
+45,073
+1% +$1.27M
SO icon
47
Southern Company
SO
$108B
$123M 0.39%
2,301,033
+148,170
+7% +$7.45M
BCE icon
48
BCE
BCE
$20.8B
$123M 0.39%
2,612,800
+386,225
+17% +$17.9M
WMT icon
49
Walmart Inc
WMT
$909B
$118M 0.37%
4,844,115
+53,781
+1% +$1.24M
AMZN icon
50
Amazon
AMZN
$2.44T
$117M 0.37%
3,279,160
+191,260
+6% +$6.47M

Similar funds

Raymond James & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Raymond James & Associates held 3,195 positions worth $31.9B, up 8.1% from $29.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.7B of net new capital in Q2 2016, opening 265 new positions and adding to 1,619 existing holdings. Its largest new stake was Schwab US REIT ETF: 467,710 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.6% of assets, up from 9% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was WisdomTree Europe Hedged Equity Fund, an estimated $43.1M trimmed.

  • Raymond James & Associates's largest Q2 2016 buy was Schwab US REIT ETF: 467,710 shares worth $10.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2016, an estimated $107M increase.
  • Raymond James & Associates's biggest Q2 2016 reduction was WisdomTree Europe Hedged Equity Fund, cutting an estimated $43.1M.
  • Raymond James & Associates fully exited ADT Corp in Q2 2016, selling an estimated $34.4M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $31.9B portfolio in Q2 2016.
  • Raymond James & Associates opened 265 new positions and closed 182 in Q2 2016.
  • Raymond James & Associates's portfolio value rose 8.1% quarter-over-quarter to $31.9B.

Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.